Skip to main
VTR

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 13%
Buy 67%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Ventas possesses a diversified healthcare portfolio comprising nearly 1,400 properties across multiple sectors, including senior housing, medical office, and skilled nursing, which positions it well for growth amid rising demand in the healthcare industry. The company's strategic focus on mature healthcare systems in Canada and the United Kingdom further enhances its investment appeal, as it seeks opportunities in markets similar to that of the United States. Additionally, Ventas's relatively well-diversified geographic footprint, along with its ongoing risk management efforts in key regions, supports its resilience and capacity to sustain occupancy and rental growth despite competitive pressures in the healthcare real estate market.

Bears say

Ventas faces a challenging outlook due to potential reductions in Medicare and Medicaid reimbursements, which could adversely affect its rent coverage ratios and necessitate rent restructuring or reductions. Additionally, the ongoing decline in the supply of skilled nursing beds, combined with barriers to entry for new facilities, may limit future growth opportunities in this sector. Furthermore, Ventas's tenant concentration exposes the firm to heightened risk, particularly as the healthcare REIT sector is expected to underperform in a rising interest rate environment, complicating access to vital capital markets.

Ventas (VTR) has been analyzed by 15 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 67% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 15 analysts, Ventas (VTR) has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.